Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 05:52 PM IST · BSE ID: 906fd10c-ab96-438d-b9cf-516fb1b1f9b6
View Original BSE Filing (PDF)
💡
In Simple Terms
Fermenta Biotech's board will meet on August 11, 2026, to review its financial results for April-June 2026.
🤖 AI Summary
- Fermenta Biotech Ltd. Board Meeting scheduled for Tuesday, August 11, 2026.
- Meeting agenda includes considering and approving unaudited financial results (standalone and consolidated) for Q1 FY27.
- Financial results pertain to the quarter ended June 30, 2026, as per Regulation 29 of SEBI LODR.
- Trading Window for company securities closed from July 1, 2026, until 48 hours post-results declaration.
- Prohibition on trading applies to Directors, Promoters, Insiders, and Designated Persons during the closure.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any action based on this specific Board Meeting notice.
👤
Who Is Affected
Directors, Promoters, Insiders, Designated Persons, their immediate relatives, and Connected Persons are restricted from trading company securities from July 1, 2026, until 48 hours after the results declaration on August 11, 2026.
🔍
Management Signal
Management is adhering to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding financial disclosures and trading window closures.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board Meeting Outcome on August 11, 2026 — for Q1 FY27 financial results.
Declaration of unaudited financial results for the quarter ended June 30, 2026.
Reopening of trading window — 48 hours after the financial results are declared.
LOW RISK
This filing is a standard regulatory compliance announcement with no inherent risks identified.
💡 Investor Takeaway
Fermenta Biotech Ltd. scheduled a Board Meeting on August 11, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, adhering to Regulation 29 of SEBI LODR. The trading window remains closed until 48 hours after results are declared.
❓ Frequently Asked Questions
When is Fermenta Biotech Ltd.'s Board Meeting scheduled?
The Board of Directors meeting for Fermenta Biotech Ltd. is scheduled to be held on Tuesday, August 11, 2026.
What is the primary agenda for Fermenta Biotech Ltd.'s Board Meeting on August 11, 2026?
The primary agenda for the Board Meeting is to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026.
When did the trading window close for Fermenta Biotech Ltd.'s securities?
The Trading Window for Fermenta Biotech Ltd.'s securities closed with effect from July 1, 2026.
When will the trading window reopen for Fermenta Biotech Ltd.?
The Trading Window will continue to remain closed till 48 hours after the declaration of unaudited financial results pursuant to the Board meeting on August 11, 2026.
Questions based on this BSE filing only. For information purposes.